Search results
Spero Therapeutics, Inc. (SPRO) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Zacks via Yahoo Finance· 2 years agoSpero Therapeutics, Inc. (SPRO) witnesses a hammer chart pattern, indicating support found by the...
Spero (SPRO) Skyrockets 168% on Licensing Deal With GSK
Zacks via Yahoo Finance· 2 years agoShares of Spero Therapeutics SPRO surged 168% after it announced an exclusive license agreement with...
Biotech Stock Roundup: GILD's Updates, FMTX Up on NVO Deal, SPRO Surges & More
Zacks via Yahoo Finance· 2 years agoDrug approvals and other regulatory updates are in focus in the biotech sector. The sector is also...
Spero Therapeutics, Inc. (SPRO) Reports Q2 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 2 years agoSpero Therapeutics, Inc. (SPRO) delivered earnings and revenue surprises of 1.14% and 13.35%,...
Spero Therapeutics, Inc.'s (NASDAQ:SPRO) Stock's On An Uptrend: Are Strong Financials Guiding The...
Simply Wall St. via Yahoo Finance· 2 months agoMost readers would already be aware that Spero Therapeutics' (NASDAQ:SPRO) stock increased...
Shareholders in Spero Therapeutics (NASDAQ:SPRO) are in the red if they invested three years ago
Simply Wall St. via Yahoo Finance· 3 weeks agoSpero Therapeutics, Inc. (NASDAQ:SPRO) shareholders should be happy to see the share price up 23% in...
Industry Analysts Just Upgraded Their Spero Therapeutics, Inc. (NASDAQ:SPRO) Revenue Forecasts By...
Simply Wall St. via Yahoo Finance· 1 year agoShareholders in Spero Therapeutics, Inc. (NASDAQ:SPRO) may be thrilled to learn that the analysts...
Spero Therapeutics, Inc.'s (NASDAQ:SPRO) Price Is Right But Growth Is Lacking After Shares Rocket...
Simply Wall St. via Yahoo Finance· 1 year agoSpero Therapeutics, Inc. (NASDAQ:SPRO) shareholders are no doubt pleased to see that the share price...
Spero Therapeutics, Inc. (SPRO) Expected to Beat Earnings Estimates: Should You Buy?
Zacks via Yahoo Finance· 2 years agoSpero Therapeutics, Inc. (SPRO) possesses the right combination of the two key ingredients for a...
Spero Therapeutics (NASDAQ:SPRO) adds US$10m to market cap in the past 7 days, though investors from...
Simply Wall St. via Yahoo Finance· 1 year agoSpero Therapeutics, Inc. (NASDAQ:SPRO) shareholders should be happy to see the share price up 18% in...